By 2050, over half of the adults and one third of the youth may be obese. Experts have called for urgent action to prevent obesity from becoming the global norm.
The once-daily pill combines Opko’s long-acting GLP-1/glucagon dual agonist peptide, dubbed OPK-88006, with Entera’s N-Tab ...
Not just in terms of health care costs — obesity can lead to diabetes, heart disease and cancer — but in productivity as well ...
UD researchers discover that differences in gene expression in fat could be the key to targeted obesity treatment. According ...
Body mass index (BMI) was almost three times more likely to classify children as overweight than waist circumference-to-height ratio, according to a new study.